Purpose: Pre-clinical irradiation systems use kilovoltage x-ray systems to deliver small fields of radiation in static beam arrangements or arcs. The systems are costly and the radiobiological effectiveness of kilovoltage beams is known to differ from the megavoltage photon beams used clinically. This work used Developer mode on the Varian TrueBeam STx linear accelerator to create a pre-clinical irradiator capable of treating millimeter-sized targets.
Materials And Methods: A treatment field defined by a single opposed leaf pair was used to deliver arc-based treatments. Dynamic couch trajectories were used to create a shortened virtual isocentre. Initially, a pre-treatment imaging procedure was used to quantify target misalignment at control points along the arcs and determine appropriate couch positional corrections. This was followed by the treatment arcs in which the positional corrections were implemented. Monte Carlo simulations and radiochromic film were used to calculate and measure dose distributions.
Results: A 1 mm leaf separation produced the optimal dose distributions. Couch position corrections up to 2.1 mm were required to maintain a target at virtual isocentre. Application of couch corrections reduced non-coplanar arc treatments dose profile by 1.2 mm at 30% of the maximum dose. Treatment of a 1 mm diameter target would result in falloff distances to the 80%, 50% and 25% of the 90% prescription line of 0.3 mm, 0.5 mm and 1.3 mm from the target edge respectively.
Conclusions: This work has demonstrated that it is possible to deliver highly compact dose distributions using megavoltage photon beams from existing clinical infrastructure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejmp.2019.01.006 | DOI Listing |
Mol Ther
January 2025
Faculty of Biology, Medicine & Health, University of Manchester, Manchester, M13 9PT, UK. Electronic address:
Optogenetic therapy is a promising vision restoration method where light sensitive opsins are introduced to the surviving inner retina following photoreceptor degeneration. The cell type targeted for opsin expression will likely influence the quality of restored vision. However, a like-for-like pre-clinical comparison of visual responses evoked following equivalent opsin expression in the two major targets, ON bipolar (ON BCs) or retinal ganglion cells (RGCs), is absent.
View Article and Find Full Text PDFJ Clin Exp Dent
December 2024
Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, SP, Brazil.
Background: Radiotherapy is one of the main treatments for head and neck cancer; however, due to its non-selectivity the glandular tissue can be affected. This scoping review aimed to identify the evidence about mesenchymal stem cell therapies for irradiated salivary gland regeneration.
Material And Methods: Two independent reviewers performed a literature search in MEDLINE/PubMed, Scopus, and Web of Science.
J Neurol
January 2025
Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, Robinson Way, Cambridge, CB2 0PY, UK.
Ataxia-Telangiectasia (A-T) is a very rare multisystem disease of DNA repair, associated with progressive disabling neurological symptoms, respiratory failure, immunodeficiency and cancer predisposition, leading to premature death. There are no curative treatments available for A-T but clinical trials have begun. A major limiting factor in effectively evaluating therapies for A-T is the lack of suitable outcome measures and biomarkers.
View Article and Find Full Text PDFSmall
January 2025
Department of Chemistry, McGill University, 801, Sherbrooke St. West, Montreal, QC, H3A 0B8, Canada.
Oligonucleotide therapeutics, including antisense oligonucleotides and small interfering RNA, offer promising avenues for modulating the expression of disease-associated proteins. However, challenges such as nuclease degradation, poor cellular uptake, and unspecific targeting hinder their application. To overcome these obstacles, spherical nucleic acids have emerged as versatile tools for nucleic acid delivery in biomedical applications.
View Article and Find Full Text PDFPhys Eng Sci Med
January 2025
School of Clinical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Set-up errors are a problem for pre-clinical irradiators that lack imaging capabilities. The aim of this study was to investigate the impact of the potential set-up errors on the dose distribution for a mouse with a xenographic tumour irradiated with a standard Cs-137 cell irradiator equipped with an in-house lead collimator with 10 mm diameter apertures. The EGSnrc Monte-Carlo (MC) code was used to simulate the potential errors caused by displacements of the mouse in the irradiation setup.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!